Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 261-270 of 2904 for cancer

Edit search filters
  1. Phase 1/2 Study Of Silevertinib (BDTX-1535) In Patients With Glioblastoma Or Non-Small Cell Lung Cancer With EGFR Mutations

    Jacksonville, FL, Rochester, MN

  2. Study Of Targeted Therapy Vs. Chemotherapy In Patients With Thyroid Cancer

    Jacksonville, FL, Rochester, MN

  3. Metformin Hydrochloride And Combination Chemotherapy In Treating Patients With Stage III-IV Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

    Rochester, MN

  4. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer

    Rochester, MN

  5. Study Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study To Investigate The Safety And Efficacy Of SAR446523 Injected Subcutaneously In Adult Participants With Relapsed/Refractory Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Study Of CG0070 Given In Combination With Pembrolizumab, In Non Muscle Invasive Bladder Cancer, Unresponsive To Bacillus Calmette-Guerin

    Rochester, MN

  8. A Study To Learn About The Medicine Called PF-08634404 Dosed Alone And In Combination With Other Anticancer Therapies In Adults With Locally Advanced Or Metastatic Renal Cell Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Pertuzumab And Trastuzumab As Neoadjuvant Treatment In Patients With HER2-Positive Breast Cancer

    Rochester, MN

  10. Proton Therapy For Partial Breast Irradiation In Early Stage Breast Cancer

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer